For the millions of adults living with obsessive-compulsive disorder — and the clinicians treating them — the dominant serotonin-deficit narrative has long felt incomplete. A comprehensive review now synthesizes converging biological evidence that reframes OCD as a multi-system condition, with implications for anyone seeking more effective or personalized treatment options.
The review, published in Annual Review of Clinical Psychology, identifies hyperactivity in cortico-striato-thalamo-cortical circuits as among the most replicated neuroimaging findings in OCD, with these patterns frequently normalizing after effective treatment — suggesting circuit-level change is a measurable outcome, not just symptom relief. Critically, the authors argue that serotonin reuptake inhibitors, while efficacious, do not validate a simple serotonin-deficit model; the mechanism of benefit remains incompletely understood. Glutamate neurotransmission is flagged as a promising next frontier, with early pharmacological trials targeting glutamatergic pathways showing signal. Additionally, emerging evidence implicates immune dysregulation and hormonal fluctuations as underappreciated contributors to OCD pathophysiology, opening new investigational avenues.
This review matters because it arrives at a moment when treatment-refractory OCD remains a serious clinical problem — roughly 40–60% of patients achieve only partial response to first-line therapies. The authors' explicit call for non-reductionist integration of biological, psychological, and social frameworks is analytically significant: it resists the trend toward purely biomedical explanations while still taking neuroscience seriously. For readers interested in longevity and cognitive healthspan, OCD's links to immune and hormonal systems suggest it may share mechanistic terrain with other inflammatory brain conditions. The review's assessment of anatomically targeted interventions — deep brain stimulation and related approaches for refractory cases — signals that precision psychiatry is moving from theoretical to translational. This is a high-quality synthesis, though the glutamate and immune findings remain largely preliminary; they should be read as hypothesis-generating rather than practice-changing.
